Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

Clinical trial NCT03850964 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03850964
Sponsor: Cure HHT
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hereditary Hemorrhagic Telangiectasia Epistaxis Anemia Nosebleed HHT

Start date: 2023-05-08
Primary completion: 2025-11-21
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.